Annual Current Assets
$8.26 M
-$45.54 M-84.64%
December 31, 2023
Summary
- As of February 7, 2025, TCRT annual total current assets is $8.26 million, with the most recent change of -$45.54 million (-84.64%) on December 31, 2023.
- During the last 3 years, TCRT annual current assets has fallen by -$122.33 million (-93.67%).
- TCRT annual current assets is now -94.58% below its all-time high of $152.52 million, reached on December 31, 2015.
Performance
TCRT Current Assets Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Current Assets
$3.55 M
-$1.13 M-24.11%
September 30, 2024
Summary
- As of February 7, 2025, TCRT quarterly total current assets is $3.55 million, with the most recent change of -$1.13 million (-24.11%) on September 30, 2024.
- Over the past year, TCRT quarterly current assets has dropped by -$1.13 million (-24.11%).
- TCRT quarterly current assets is now -98.15% below its all-time high of $191.62 million, reached on March 31, 2020.
Performance
TCRT Quarterly Current Assets Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Current Assets Formula
Current Assets = Cash and Equivalents + Accounts Receivable + Inventory + Prepaid Expenses + Marketable Securities + Other Current Assets
TCRT Current Assets Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -84.6% | -24.1% |
| 3 y3 years | -93.7% | -96.3% |
| 5 y5 years | -90.2% | -97.7% |
TCRT Current Assets Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -89.5% | at low | -95.5% | at low |
| 5 y | 5-year | -93.7% | at low | -98.2% | at low |
| alltime | all time | -94.6% | -100.0% | -98.2% | -100.0% |
Alaunos Therapeutics Current Assets History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $3.55 M(-24.1%) |
| Jun 2024 | - | $4.68 M(-22.5%) |
| Mar 2024 | - | $6.04 M(-26.9%) |
| Dec 2023 | $2000.00(-100.0%) | $8.26 M(-35.8%) |
| Sep 2023 | - | $12.87 M(-31.5%) |
| Jun 2023 | - | $18.78 M(-50.8%) |
| Mar 2023 | - | $38.18 M(-29.0%) |
| Dec 2022 | $11.14 M(-30.5%) | $53.80 M(-3.1%) |
| Sep 2022 | - | $55.51 M(-9.5%) |
| Jun 2022 | - | $61.36 M(-12.1%) |
| Mar 2022 | - | $69.77 M(-11.5%) |
| Dec 2021 | $16.03 M(+1.8%) | $78.83 M(-18.4%) |
| Sep 2021 | - | $96.55 M(+8.0%) |
| Jun 2021 | - | $89.41 M(-20.7%) |
| Mar 2021 | - | $112.71 M(-13.7%) |
| Dec 2020 | $15.76 M(+335.0%) | $130.59 M(-15.8%) |
| Sep 2020 | - | $155.07 M(-10.5%) |
| Jun 2020 | - | $173.18 M(-9.6%) |
| Mar 2020 | - | $191.62 M(+81.6%) |
| Dec 2019 | $3.62 M(-66.4%) | $105.49 M(-8.7%) |
| Sep 2019 | - | $115.60 M(+75.5%) |
| Jun 2019 | - | $65.86 M(-11.1%) |
| Mar 2019 | - | $74.09 M(-12.1%) |
| Dec 2018 | $10.77 M(-27.4%) | $84.28 M(+78.7%) |
| Sep 2018 | - | $47.16 M(-11.0%) |
| Jun 2018 | - | $52.99 M(-26.5%) |
| Mar 2018 | - | $72.11 M(-20.6%) |
| Dec 2017 | $14.82 M(+912.5%) | $90.78 M(-21.0%) |
| Sep 2017 | - | $114.89 M(-8.2%) |
| Jun 2017 | - | $125.13 M(+34.9%) |
| Mar 2017 | - | $92.75 M(-11.6%) |
| Dec 2016 | $1.46 M(+21.7%) | $104.88 M(-9.3%) |
| Sep 2016 | - | $115.68 M(-8.7%) |
| Jun 2016 | - | $126.71 M(-9.7%) |
| Mar 2016 | - | $140.39 M(-8.0%) |
| Dec 2015 | $1.20 M(+4.6%) | $152.52 M(-11.6%) |
| Sep 2015 | - | $172.48 M(+40.1%) |
| Jun 2015 | - | $123.08 M(-5.8%) |
| Mar 2015 | - | $130.60 M(+196.2%) |
| Dec 2014 | $1.15 M(-21.1%) | $44.09 M(-7.8%) |
| Sep 2014 | - | $47.81 M(-11.5%) |
| Jun 2014 | - | $54.02 M(-12.9%) |
| Mar 2014 | - | $62.00 M(-11.8%) |
| Dec 2013 | $1.46 M(-53.4%) | $70.30 M(+157.7%) |
| Sep 2013 | - | $27.27 M(-36.6%) |
| Jun 2013 | - | $43.03 M(-28.9%) |
| Mar 2013 | - | $60.56 M(-24.6%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2012 | $3.13 M(+56.2%) | $80.28 M(-21.7%) |
| Sep 2012 | - | $102.58 M(-14.1%) |
| Jun 2012 | - | $119.44 M(-14.0%) |
| Mar 2012 | - | $138.81 M(+30.8%) |
| Dec 2011 | $2.00 M(+184.5%) | $106.11 M(-11.9%) |
| Sep 2011 | - | $120.42 M(-8.3%) |
| Jun 2011 | - | $131.30 M(+1.0%) |
| Mar 2011 | - | $129.97 M(+113.7%) |
| Dec 2010 | $704.00 K(+29.7%) | $60.82 M(-9.0%) |
| Sep 2010 | - | $66.82 M(-9.6%) |
| Jun 2010 | - | $73.94 M(+63.0%) |
| Mar 2010 | - | $45.36 M(-7.8%) |
| Dec 2009 | $543.00 K(-37.4%) | $49.19 M(+560.3%) |
| Sep 2009 | - | $7.45 M(+58.6%) |
| Jun 2009 | - | $4.70 M(-33.0%) |
| Mar 2009 | - | $7.01 M(-40.2%) |
| Dec 2008 | $867.00 K(-27.7%) | $11.71 M(-25.8%) |
| Sep 2008 | - | $15.77 M(-26.1%) |
| Jun 2008 | - | $21.33 M(-23.4%) |
| Mar 2008 | - | $27.82 M(-21.7%) |
| Dec 2007 | $1.20 M(+87.7%) | $35.53 M(-14.6%) |
| Sep 2007 | - | $41.63 M(-12.4%) |
| Jun 2007 | - | $47.51 M(-10.8%) |
| Mar 2007 | - | $53.28 M(+84.5%) |
| Dec 2006 | $638.70 K(+59.8%) | $28.87 M(-17.1%) |
| Sep 2006 | - | $34.81 M(-6.8%) |
| Jun 2006 | - | $37.35 M(+535.7%) |
| Mar 2006 | - | $5.88 M(-35.4%) |
| Dec 2005 | $399.70 K(+32.9%) | $9.09 M(-17.0%) |
| Sep 2005 | - | $10.95 M(>+9900.0%) |
| Jun 2005 | - | $1100.00(+1000.0%) |
| Mar 2005 | - | $100.00(-100.0%) |
| Dec 2004 | $300.80 K(>+9900.0%) | $1.14 M(>+9900.0%) |
| Sep 2004 | - | $0.00(0.0%) |
| Jun 2004 | - | $0.00(-100.0%) |
| Mar 2004 | - | $4600.00(>+9900.0%) |
| Dec 2003 | $0.00(-100.0%) | $0.00(0.0%) |
| Sep 2003 | - | $0.00(-100.0%) |
| Jun 2003 | - | $100.00(-99.0%) |
| Mar 2003 | - | $9900.00(>+9900.0%) |
| Dec 2002 | $500.00(-50.0%) | $0.00(0.0%) |
| Sep 2002 | - | $0.00(-100.0%) |
| Jun 2002 | - | $1000.00(-81.1%) |
| Mar 2002 | - | $5300.00(+178.9%) |
| Dec 2001 | $1000.00 | $1900.00(-42.4%) |
| Sep 2001 | - | $3300.00(-62.9%) |
| Jun 2001 | - | $8900.00 |
FAQ
- What is Alaunos Therapeutics annual total current assets?
- What is the all time high annual current assets for Alaunos Therapeutics?
- What is Alaunos Therapeutics annual current assets year-on-year change?
- What is Alaunos Therapeutics quarterly total current assets?
- What is the all time high quarterly current assets for Alaunos Therapeutics?
- What is Alaunos Therapeutics quarterly current assets year-on-year change?
What is Alaunos Therapeutics annual total current assets?
The current annual current assets of TCRT is $8.26 M
What is the all time high annual current assets for Alaunos Therapeutics?
Alaunos Therapeutics all-time high annual total current assets is $152.52 M
What is Alaunos Therapeutics annual current assets year-on-year change?
Over the past year, TCRT annual total current assets has changed by -$45.54 M (-84.64%)
What is Alaunos Therapeutics quarterly total current assets?
The current quarterly current assets of TCRT is $3.55 M
What is the all time high quarterly current assets for Alaunos Therapeutics?
Alaunos Therapeutics all-time high quarterly total current assets is $191.62 M
What is Alaunos Therapeutics quarterly current assets year-on-year change?
Over the past year, TCRT quarterly total current assets has changed by -$1.13 M (-24.11%)